Akebia Therapeutics (AKBA) Ownership - Who Owns Akebia Therapeutics?

1,638 Followers

Akebia Therapeutics (AKBA) Ownership Overview

2.85% Insiders

8.72% Mutual Funds

0.19% Other Institutional Investors

12.80% ETFs

75.44% Public Companies and Individual Investors

The ownership structure of Akebia Therapeutics (AKBA) stock is a mix of institutional, retail, and individual investors. Approximately 21.71% of the company’s stock is owned by Institutional Investors, 2.85% is owned by Insiders, and 75.44% is owned by Public Companies and Individual Investors.

The ownership structure of Akebia Therapeutics (AKBA) stock is a mix of institutional, retail, and individual investors. Approximately 8.91% of the company’s stock is owned by Institutional Investors, 2.85% is owned by Insiders, and 12.80% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Mar 05, 2026	John P. Butler	xxxxxxxxxxxxx	$86588

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Sep 30, 2023	Graham Capital Management, L.p.	xxxxxxxxxxxxx	$606268
Sep 30, 2023	Entrypoint Capital, Llc	xxxxxxxxxxxxx	$205277

Show More Hedge Fund Trading Activity >

Top Shareholders

# of Shares	Type	% Holding	Value
13,110,133	Institution	4.89%	18,747,490
10,795,143	Institution	4.03%	15,437,054
9,719,870	Institution	3.63%	13,899,414
7,028,322	Institution	2.62%	10,050,500
3,526,992	Insider	1.32%	5,043,599
2,764,213	Institution	1.03%	3,952,825
2,623,743	Institution	0.98%	3,751,952
1,417,532	Institution	0.53%	2,027,071
1,286,249	Institution	0.48%	1,839,336
1,209,806	Institution	0.45%	1,730,023

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
10,795,143	Institution	4.03%	15,437,054
2,764,213	Institution	1.03%	3,952,825
2,623,743	Institution	0.98%	3,751,952
1,417,532	Institution	0.53%	2,027,071
763,489	Institution	0.29%	1,091,789
746,039	Institution	0.28%	1,066,836
720,848	Institution	0.27%	1,030,813
534,187	Institution	0.20%	763,887
501,389	Institution	0.19%	716,986
396,648	Institution	0.15%	567,207

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	7,912,283	Institution	2.95%	10,998,073
SPDR S&P BIOTECH ETF	6,623,184	Institution	2.47%	9,471,153
iShares Russell 2000 ETF	5,907,069	Institution	2.21%	8,447,109
Vanguard Extended Market ETF	2,982,409	Institution	1.11%	4,145,549
iShares Russell 2000 Value ETF	1,964,617	Institution	0.73%	2,809,402
Schwab U.S. Small-Cap ETF	1,286,249	Institution	0.48%	1,839,336
Vanguard Russell 2000 ETF	1,243,427	Institution	0.46%	1,728,364
Fidelity Enhanced Small Cap ETF	1,209,720	Institution	0.45%	1,729,900
Vanguard Health Care ETF	754,944	Institution	0.28%	1,049,372
iShares Micro-Cap ETF	642,613	Institution	0.24%	918,937

FAQ

Who Owns Akebia Therapeutics (AKBA)?

According to the latest TipRanks data, approximately 0.19% of the company's stock is held by institutional investors, 2.85% is held by insiders, and 75.44% is held by retail investors.

What percentage of Akebia Therapeutics (AKBA) stock is held by institutional investors?

According to the latest TipRanks data, approximately 0.19% of Akebia Therapeutics (AKBA) stock is held by institutional investors.

What percentage of Akebia Therapeutics (AKBA) stock is held by retail investors?

According to the latest TipRanks data, approximately 75.44% of Akebia Therapeutics (AKBA) stock is held by retail investors.

Who owns the most shares of Akebia Therapeutics (AKBA)?

Vanguard owns the most shares of Akebia Therapeutics (AKBA).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.